Volume 15, Number 9—September 2009
Research
Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, England
Table 1
Exposure domain and variable | Odds ratio | 95% Confidence interval | p value |
---|---|---|---|
Health details | |||
Previous Campylobacter infection | 2.20 | 1.33–3.64 | 0.002 |
Use of acid-suppressing medication in previous 28 days |
3.39 |
2.49–4.62 |
<0.001 |
Pets | |||
Pet fish | 0.56 | 0.33–0.94 | 0.029 |
If last pet acquired was a dog, how long ago was it acquired? | |||
Dog was not last pet bought/no pets | 1.00 | – | – |
>6 months ago | 0.76 | 0.57–1.01 | 0.057 |
3–6 months ago | 1.30 | 0.53–3.16 | 0.566 |
1–3 months ago | 1.74 | 0.62–4.93 | 0.296 |
2–4 weeks ago | 14.40 | 3.69–56.14 | <0.001 |
<2 weeks ago |
1.08 |
0.12–9.90 |
0.946 |
Food | |||
No. times salads eaten per week | |||
0 | 1.00 | – | – |
1 | 0.89 | 0.63–1.26 | 0.503 |
2 | 0.58 | 0.40–0.82 | 0.002 |
3 | 0.72 | 0.49–1.05 | 0.086 |
4 | 0.93 | 0.62–1.40 | 0.739 |
>5 | 0.63 | 0.44–0.91 | 0.013 |
No. times legumes eaten per week | |||
0 | 1.00 | – | – |
1 | 0.65 | 0.51–0.84 | 0.001 |
2 | 0.57 | 0.44–0.75 | <0.001 |
3 | 0.47 | 0.33–0.68 | <0.001 |
4 | 0.65 | 0.40–1.05 | 0.078 |
>5 | 0.66 | 0.42–1.04 | 0.071 |
No. times fruit eaten per week | |||
0 | 1.00 | – | – |
1 | 0.95 | 0.53–1.69 | 0.860 |
2 | 1.57 | 0.96–2.55 | 0.071 |
3 | 1.19 | 0.71–1.98 | 0.518 |
4 | 1.77 | 1.05–2.98 | 0.032 |
>5 | 1.06 | 0.70–1.61 | 0.775 |
No. times chicken eaten per week | |||
0 | 1.00 | – | – |
1 | 1.62 | 0.98–2.68 | 0.058 |
2 | 1.96 | 1.16–3.32 | 0.012 |
3 | 1.70 | 0.98–2.95 | 0.061 |
4 | 2.10 | 1.16–3.79 | 0.014 |
>5 | 3.74 | 2.06–6.80 | <0.001 |
Regularly drinks raw milk | 1.00 | – | – |
Rarely/never | |||
Yes, regularly | 0.24 | 0.08–0.72 | 0.010 |
Yes, occasionally | 0.70 | 0.33–1.51 | 0.365 |
Location where chicken eaten in past 5 days was prepared | |||
No chicken eaten | 1.00 | – | – |
In the home/someone else's home only | 0.70 | 0.49–1.00 | 0.050 |
Outside the home only | 1.95 | 1.26–3.01 | 0.003 |
In the home and outside the home | 0.70 | 0.48–1.03 | 0.069 |
1The Campylobacter Case–Control Study Group comprises the following: Sarah J. O’Brien (Manchester University); Clarence C. Tam, Craig D. Higgins, Laura C. Rodrigues, and Brendan W. Wren (London School of Hygiene and Tropical Medicine); Keith R. Neal (University of Nottingham); Bob Owen and Judith Richardson (Health Protection Agency Centre for Infections); Bharat C. Patel (Health Protection Agency Collaborating Centre, North Middlesex Hospital); Peter Sheridan (North East and Central London HPU); John Curnow (Cheshire and Merseyside HPU); Ken Lamden (Cumbria and Lancashire HPU); and Sally Millership (Essex HPU).
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.